Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 359-363

  Dawson, Raymond M ^a   McAllister, Jane ^a   Liu, Chun Qiang ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Anthrax; Antimicrobial; Cytotoxicity; Haemolysis; Melioidosis; SMAP 29

Indexed keywords

ALPHA INTERMEDIN; CAERIN 1.1; CALCITERMIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN A; CITROPIN 1.1; DEFENSIN; ENKELYTIN; HISTONE H2A; KIGAKI; MAGAININ DERIVATIVE; MAXIMIM H5; METALNIKOWIN 2A; METCHNIKOWIN; MUNDTICIN; ONCORHYNCIN I; ONCORHYNCIN III; PLECTASIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN 1; PROTEIN BACR1; PROTEIN HNP 1; PROTEIN P3; PROTEIN PEP 1 K; SAPECIN C; SHEEP MYELOID ANTIMICROBIAL PEPTIDE 29; SPINIGERIN; TEMPORIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; UPERIN 7.1;

ARTICLE; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIAL GROWTH; BURKHOLDERIA; BURKHOLDERIA THAILANDENSIS; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; EMBRYO; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS; BACILLUS ANTHRACIS; BLOOD PROTEINS; BURKHOLDERIA; ERYTHROCYTES; HEK293 CELLS; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SHEEP, DOMESTIC;

EID: 77955927935     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.038     Document Type: Article

References (13)

1. Dawson R.M., Liu C.-Q. Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit Rev Microbiol 2008, 34:89-107.
2. Mayer-Scholl A., Hurwitz R., Brinkmann V., Schmid M., Jungblut P., Weinrauch Y., et al. Human neutrophils kill Bacillus anthracis. PLoS Pathog 2005, 1:e23.
3. Wang W., Mulakala C., Ward S.C., Jung G., Luong H., Pham D., et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006, 281:32755-32764.
4. Thwaite J.E., Hibbs S., Titball R.W., Atkins T.P. Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother 2006, 50:2316-2322.
5. Lisanby M.W., Swiecki M.K., Dizon B.L.P., Pflughoeft K.J., Koehler T.M., Kearney J.F. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol 2008, 181:4989-5000.
6. Whiteaker J.R., Warscheid B., Pribil P., Hathout Y., Fenselau C. Complete sequences of small acid-soluble proteins from Bacillus globigii. J Mass Spectrom 2004, 39:1113-1121.
7. Yu Y., Kim H.S., Chua H.H., Lin C.H., Sim S.H., Lin D., et al. Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiol 2006, 6:46.
8. Jin F., Xu X., Wang L., Zhang W., Gu D. Expression of recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) in Pichia pastoris: purification and characterization. Prot Expr Purif 2006, 50:147-156.
9. Dawson R.M., Liu C.-Q. Cathelicidin peptide SMAP-29: comprehensive review of its properties and potential as a novel class of antibiotic. Drug Dev Res 2009, 70:481-498.
10. Strandberg E., Tiltak D., Ieronimo M., Kanithasen N., Wadhwani P., Ulrich A.S. Influence of C-terminal amidation on the antimicrobial and haemolytic activities of cationic α-helical peptides. Pure Appl Chem 2007, 79:717-728.
11. Smith V.T., Fernandes J.M.O., Jones S.J., Kemp G.D., Tatner M.F. Antibacterial proteins in rainbow trout, Oncorhynchus mykiss. Fish Shellfish Immunol 2000, 10:243-260.
12. Niu M., Li X., Wei J., Cao R., Zhou B., Chen P. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity. Prot Expr Purif 2008, 57:95-100.
13. Pini A., Runci Y., Falciani C., Lelli B., Brunetti J., Pileri S., et al. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Biochem J 2006, 395:157-163.